semaglutide ema approval EU Extends Ozempic Review to Include More Weight-Loss, Diabetes Drugs Viral immunotherapy gets EU approval

Direct hormonal effects: GLP-1 medications don't replace or significantly alter estrogen or progesterone levels Indirect benefits: Weight loss from GLP-1s may improve hormonal imbalances related to excess body fat Key distinction: GLP-1s and HRT work through entirely different mechanisms, which is why combining them may offer complementary benefits What research shows about using HRT and GLP-1 together Emerging research suggests combining HRT with GLP-1 medications may produce better weight loss outcomes than either approach alone, with tirzepatide showing 20.9% weight reduction at 72 weeks in clinical studies

While we still have a lot to learn about their long-term risk and benefits, so far GLP-1 drugs have shown real potential for improving peoples health and well-being

A model that aligns endocrinology, nephrology, cardiology, and hepatology around shared risk pathways

HSP90 acts as a senomorphic target in senescent retinal pigmental epithelial cells

Because semaglutide does not act on the GIP receptor at all, this variant had no effect on semaglutide tolerability whatsoever